Gracell Biotechnologies Depreciation & Amortization 2011-2026 | GRCL

Annual Depreciation & Amortization Gracell Biotechnologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
44.9 M	21.6 M	5.12 M	2.99 M	-	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
44.9 M	2.99 M	18.6 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.54	-20.81 %	$ 238 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 330.34	3.6 %	$ 43.3 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.89	-4.33 %	$ 4.85 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AbbVie ABBV	762 M	$ 206.69	-1.01 %	$ 366 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.09	-0.97 %	$ 437 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.39	-3.69 %	$ 1.01 B	Canada
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.22	2.37 %	$ 225 M	Israel
Ardelyx ARDX	3.06 M	$ 5.97	0.51 %	$ 1.44 B	USA
Cerevel Therapeutics Holdings CERE	5.63 M	-	-	$ 7.29 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.32	-4.35 %	$ 339 M	USA